Does IL-6 induce aromatase expression and increase local estrogen production?

The relationship between chronic inflammation and hormonal imbalance is well-documented, particularly regarding the role of pro-inflammatory cytokines in modulating steroidogenesis. In aging males, chronic low-grade inflammation can significantly alter the androgen-to-estrogen ratio through the induction of the aromatase enzyme.

Mechanistic pathways of induction

The induction of CYP19A1 (the gene encoding aromatase) by interleukin-6 (IL-6) involves complex intracellular signaling, primarily localized within adipose tissue and the surrounding stroma.

• The JAK-STAT3 Axis: IL-6 secreted by macrophages and adipose-associated fibroblasts activates the Janus kinase/signal transducer and activator of transcription 3 (JAK-STAT3) pathway. This activation is a primary driver of CYP19A1 upregulation.
• Transcriptional Crosstalk: While IL-6 is a potent stimulator, its effects are often amplified by crosstalk with other inflammatory mediators. Research indicates that IL-6-induced STAT3 activation works in tandem with NF-κB and TNF-α to stimulate aromatase promoters (specifically promoter II and I.3), which are highly sensitive to inflammatory signaling.
• Tissue-Specific Activity: This mechanism is particularly active in adipose stromal cells. In males, as visceral adiposity increases with age, the concentration of "crown-like structures" (macrophage clusters) rises, creating a localized inflammatory milieu that maximizes aromatase expression.

Local estrogen production and clinical evidence

The upregulation of aromatase leads to a direct increase in the conversion of testosterone into estradiol (E2), creating a localized hyperestrogenic state.

• Conversion Metrics: Aromatase catalyzes the irreversible conversion of androgens. Studies in human adipose samples and mouse models confirm that elevated cytokine levels correlate with a measurable shift in the estradiol-to-testosterone (E2/T) ratio.
• Systemic vs. Local Effects: While systemic estrogen levels may remain within the high-normal range, local tissue concentrations—especially in breast and adipose tissue—can be significantly higher due to this cytokine-driven induction.
• The Obesity-Inflammation-Aromatase Axis: Evidence from clinical research shows that this axis is a self-perpetuating cycle; increased estrogen can promote further adiposity, which in turn recruits more macrophages, further elevating IL-6 and aromatase activity.

Bottom line

The claim that IL-6 induces aromatase expression and increases local estrogen production is strongly supported by scientific evidence. This mechanism, driven by the JAK-STAT3 and NF-κB pathways, explains how chronic inflammation contributes to hormonal imbalances and decreased bioavailable testosterone in males.